The efficacy of partial versus total splenectomy in the treatment of hereditary spherocytosis in children: a systematic review and meta-analysis.
Hereditary spherocytosis
Meta-analysis
Near-total splenectomy
Partial splenectomy
Total splenectomy
Journal
Pediatric surgery international
ISSN: 1437-9813
Titre abrégé: Pediatr Surg Int
Pays: Germany
ID NLM: 8609169
Informations de publication
Date de publication:
29 Oct 2024
29 Oct 2024
Historique:
accepted:
20
10
2024
medline:
29
10
2024
pubmed:
29
10
2024
entrez:
29
10
2024
Statut:
epublish
Résumé
To explore the comparative postoperative efficacy of partial splenectomy (PS) and total splenectomy (TS) in the treatment of children with hereditary spherocytosis (HS). The relevant HS studies from databases were searched and screened, comparing the differences in hemoglobin concentration, reticulocyte percentage, bilirubin concentration before and after TS and PS surgery, and during the follow-up period, as well as the incidence of postoperative adverse events. Statistical analysis was performed using Review Manager 5.4. A total of 5 studies were included in this meta-analysis, with a cumulative enrollment of 312 children, 130 in the PS group and 182 in the TS group. The meta-analysis results showed that both PS and TS groups had statistically significant differences in postoperative hematological outcomes compared to before surgery, with TS showing better improvement than PS. In the postoperative follow-up, the changes in hematological outcomes between PS and TS were statistically significant for hemoglobin concentration: within 1 year [MD = 1.85, 95%CI(1.09,2.60)], 1-2 years [MD = 1.74, 95%CI(0.25,3.24)], not statistically significant for 4-6 years [MD = 1.28, 95%CI(-1.75,4.32)]; for reticulocyte percentage: within 1 year [MD = 2.23, 95%CI(0.80,3.66)] was statistically significant, not statistically significant for 4-6 years [MD = 1.77, 95%CI(-2.04,5.59)]; for serum bilirubin concentration: within 1 year [MD = 1.55, 95%CI(0.91,2.18)] was statistically significant, not statistically significant for 1-2 years [MD = 1.77, 95%CI(-2.04,5.99)]. In the incidence of postoperative adverse events, the incidence of cholelithiasis [MD = 1.77, 95%CI(-2.04,5.99)] showed a statistically significant difference between PS and TS, while there were no statistically significant differences in other included events, such as postoperative infection rate, secondary surgery rate, thrombosis rate, postoperative hemorrhage rate, and transfusion therapy rate. Splenectomy is a beneficial surgical strategy for children with moderate-to-severe HS, reducing; early hematological outcomes of TS are more robust than PS in the follow-up period, and there is no difference between the two in the later period; for postoperative adverse events, the incidence of cholelithiasis in children after PS is higher than after TS, and there is a risk of requiring a second surgery for total splenectomy due to hemolytic recurrences.
Identifiants
pubmed: 39470805
doi: 10.1007/s00383-024-05879-7
pii: 10.1007/s00383-024-05879-7
doi:
Types de publication
Journal Article
Systematic Review
Meta-Analysis
Review
Comparative Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
280Subventions
Organisme : National Natural Science Foundation of China
ID : 82073062
Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Bolton-Maggs PHB, Stevens RF, Dodd NJ et al (2004) Guidelines for the diagnosis and management of hereditary spherocytosis. Br J Haematol 126(4):455–474. https://doi.org/10.1111/j.1365-2141.2004.05052.x
doi: 10.1111/j.1365-2141.2004.05052.x
pubmed: 15287938
Maillet P, Alloisio N, Morlé L, Delaunay J (1996) Spectrin mutations in hereditary elliptocytosis and hereditary spherocytosis. Hum Mutat 8(2):97–107. https://doi.org/10.1002/(SICI)1098-1004(1996)8:2%3c97::AID-HUMU1%3e3.0.CO;2-M
doi: 10.1002/(SICI)1098-1004(1996)8:2<97::AID-HUMU1>3.0.CO;2-M
pubmed: 8844207
Gallagher PG, Sabatino DE, Basseres DS et al (2001) Erythrocyte ankyrin promoter mutations associated with recessive hereditary spherocytosis cause significant abnormalities in ankyrin expression. J Biol Chem 276(45):41683–41689. https://doi.org/10.1074/jbc.M105844200
doi: 10.1074/jbc.M105844200
pubmed: 11527968
Thomsen RW, Schoonen WM, Farkas DK et al (2009) Risk for hospital contact with infection in patients with splenectomy: a population-based cohort study. Ann Intern Med 151(8):546–555. https://doi.org/10.7326/0003-4819-151-8-200910200-00008
doi: 10.7326/0003-4819-151-8-200910200-00008
pubmed: 19841456
Mohren M, Markmann I, Dworschak U et al (2004) Thromboembolic complications after splenectomy for hematologic diseases. Am J Hematol 76(2):143–147. https://doi.org/10.1002/ajh.20018
doi: 10.1002/ajh.20018
pubmed: 15164380
Bolton-Maggs PHB, Langer JC, Iolascon A, Tittensor P, King MJ, General Haematology Task Force of the British Committee for Standards in Haematology (2012) Guidelines for the diagnosis and management of hereditary spherocytosis–2011 update. Br J Haematol 156(1):37–49. https://doi.org/10.1111/j.1365-2141.2011.08921.x
doi: 10.1111/j.1365-2141.2011.08921.x
pubmed: 22055020
Hall BJ, Reiter AJ, Englum BR, Rothman JA, Rice HE (2020) Long-term hematologic and clinical outcomes of splenectomy in children with hereditary spherocytosis and sickle cell disease. Pediatr Blood Cancer 67(8):e28290. https://doi.org/10.1002/pbc.28290
doi: 10.1002/pbc.28290
pubmed: 37132000
pmcid: 10151035
Rogulski R, Adamowicz-Salach A, Matysiak M et al (2016) Laparoscopic splenectomy for hereditary spherocytosis-preliminary report. Eur J Haematol 96(6):637–642. https://doi.org/10.1111/ejh.12649
doi: 10.1111/ejh.12649
pubmed: 26268883
Rosman CWK, Broens PMA, Trzpis M, Tamminga RYJ (2017) A long-term follow-up study of subtotal splenectomy in children with hereditary spherocytosis. Pediatr Blood Cancer. https://doi.org/10.1002/pbc.26592.10.1002/pbc.26592
doi: 10.1002/pbc.26592.10.1002/pbc.26592
pubmed: 28417547
Seims AD, Breckler FD, Hardacker KD, Rescorla FJ (2013) Partial versus total splenectomy in children with hereditary spherocytosis. Surgery 154(4):849–855. https://doi.org/10.1016/j.surg.2013.07.019
doi: 10.1016/j.surg.2013.07.019
pubmed: 24074424
Tripodi SI, Shamberger RC, Heeney MM, Tubman VN (2019) Clinical and laboratory outcomes following total or partial splenectomy in patients with hereditary spherocytosis. Pediatr Hematol Oncol 36(6):382–389. https://doi.org/10.1080/08880018.2019.1637983
doi: 10.1080/08880018.2019.1637983
pubmed: 31347415
pmcid: 6752974
Eber SW, Armbrust R, Schröter W (1990) Variable clinical severity of hereditary spherocytosis: relation to erythrocytic spectrin concentration, osmotic fragility, and autohemolysis. J Pediatr 117(3):409–416. https://doi.org/10.1016/s0022-3476(05)81081-9
doi: 10.1016/s0022-3476(05)81081-9
pubmed: 2391596
Machado NO, Grant CS, Alkindi S et al (2009) Splenectomy for haematological disorders: a single center study in 150 patients from Oman. Int J Surg Lond Engl 7(5):476–481. https://doi.org/10.1016/j.ijsu.2009.08.004
doi: 10.1016/j.ijsu.2009.08.004
Rice HE, Oldham KT, Hillery CA, Skinner MA, O’Hara SM, Ware RE (2003) Clinical and hematologic benefits of partial splenectomy for congenital hemolytic anemias in children. Ann Surg 237(2):281–288. https://doi.org/10.1097/01.SLA.0000048453.61168.8F
doi: 10.1097/01.SLA.0000048453.61168.8F
pubmed: 12560788
pmcid: 1522140
Guizzetti L (2016) Total versus partial splenectomy in pediatric hereditary spherocytosis: a systematic review and meta-analysis. Pediatr Blood Cancer 63(10):1713–1722. https://doi.org/10.1002/pbc.26106
doi: 10.1002/pbc.26106
pubmed: 27300151
Englum BR, Rothman J, Leonard S et al (2016) Hematologic outcomes after total splenectomy and partial splenectomy for congenital hemolytic anemia. J Pediatr Surg 51(1):122–127. https://doi.org/10.1016/j.jpedsurg.2015.10.028
doi: 10.1016/j.jpedsurg.2015.10.028
pubmed: 26613837
Bisharat N, Omari H, Lavi I, Raz R (2001) Risk of infection and death among post-splenectomy patients. J Infect 43(3):182–186. https://doi.org/10.1053/jinf.2001.0904
doi: 10.1053/jinf.2001.0904
pubmed: 11798256
Cullingford GL, Watkins DN, Watts AD, Mallon DF (1991) Severe late post-splenectomy infection. Br J Surg 78(6):716–721. https://doi.org/10.1002/bjs.1800780626
doi: 10.1002/bjs.1800780626
pubmed: 2070242
Kyaw MH, Holmes EM, Toolis F et al (2006) Evaluation of severe infection and survival after splenectomy. Am J Med 119(3):276.e1–7. https://doi.org/10.1016/j.amjmed.2005.07.044
doi: 10.1016/j.amjmed.2005.07.044
pubmed: 16490477
Price VE, Dutta S, Blanchette VS et al (2006) The prevention and treatment of bacterial infections in children with asplenia or hyposplenia: practice considerations at the hospital for sick children, Toronto. Pediatr Blood Cancer 46(5):597–603. https://doi.org/10.1002/pbc.20477
doi: 10.1002/pbc.20477
pubmed: 16333816
Stoehr GA, Rose MA, Eber SW, Heidemann K, Schubert R, Zielen S (2006) Immunogenicity of sequential pneumococcal vaccination in subjects splenectomised for hereditary spherocytosis. Br J Haematol 132(6):788–790. https://doi.org/10.1111/j.1365-2141.2005.05918.x
doi: 10.1111/j.1365-2141.2005.05918.x
pubmed: 16487181
Luoto TT, Pakarinen MP, Koivusalo A (2016) Long-term outcomes after pediatric splenectomy. Surgery 159(6):1583–1590. https://doi.org/10.1016/j.surg.2015.12.014
doi: 10.1016/j.surg.2015.12.014
pubmed: 26832988
Bader-Meunier B, Gauthier F, Archambaud F et al (2001) Long-term evaluation of the beneficial effect of subtotal splenectomy for management of hereditary spherocytosis. Blood 97(2):399–403. https://doi.org/10.1182/blood.v97.2.399
doi: 10.1182/blood.v97.2.399
pubmed: 11154215
Buesing KL, Tracy ET, Kiernan C et al (2011) Partial splenectomy for hereditary spherocytosis: a multi-institutional review. J Pediatr Surg 46(1):178–183. https://doi.org/10.1016/j.jpedsurg.2010.09.090
doi: 10.1016/j.jpedsurg.2010.09.090
pubmed: 21238662
Münch AL, Jacobsen EM, Schulz A et al (2023) Long-term haematological response and maintained immunological function after laparoscopic subtotal splenectomy in patients with hereditary spherocytosis. Eur J Haematol 111(5):777–786. https://doi.org/10.1111/ejh.14077
doi: 10.1111/ejh.14077
pubmed: 37700575
Pincez T, Guitton C, Gauthier F et al (2016) Long-term follow-up of subtotal splenectomy for hereditary spherocytosis: a single-center study. Blood 127(12):1616–1618. https://doi.org/10.1182/blood-2015-11-679357
doi: 10.1182/blood-2015-11-679357
pubmed: 26773041
pmcid: 4807426
Stoehr GA, Sobh JN, Luecken J et al (2006) Near-total splenectomy for hereditary spherocytosis: clinical prospects in relation to disease severity. Br J Haematol 132(6):791–793. https://doi.org/10.1111/j.1365-2141.2005.05956.x
doi: 10.1111/j.1365-2141.2005.05956.x
pubmed: 16487182
Güngör A, Yaralı N, Fettah A, Ok-Bozkaya İ, Özbek N, Kara A (2018) Hereditary spherocytosis: retrospective evaluation of 65 children. Turk J Pediatr 60(3):264–269. https://doi.org/10.24953/turkjped.2018.03.005
doi: 10.24953/turkjped.2018.03.005
pubmed: 30511538
Liu Y, Jin S, Li Y et al (2023) Treatment of asymptomatic gallstones in children with hereditary spherocytosis requiring splenectomy. J Pediatr Surg 58(4):756–761. https://doi.org/10.1016/j.jpedsurg.2022.11.012
doi: 10.1016/j.jpedsurg.2022.11.012
pubmed: 36588038
Al-raimi K, Zheng SS (2016) Postoperative outcomes after open splenectomy versus laparoscopic splenectomy in cirrhotic patients: a meta-analysis. Hepatobiliary Pancreat Dis Int HBPD INT 15(1):14–20. https://doi.org/10.1016/s1499-3872(16)60053-x
doi: 10.1016/s1499-3872(16)60053-x
pubmed: 26818539
Rodeghiero F, Ruggeri M (2012) Short- and long-term risks of splenectomy for benign haematological disorders: should we revisit the indications? Br J Haematol 158(1):16–29. https://doi.org/10.1111/j.1365-2141.2012.09146.x
doi: 10.1111/j.1365-2141.2012.09146.x
pubmed: 22571181
Krauth MT, Lechner K, Neugebauer EAM, Pabinger I (2008) The postoperative splenic/portal vein thrombosis after splenectomy and its prevention–an unresolved issue. Haematologica 93(8):1227–1232. https://doi.org/10.3324/haematol.12682
doi: 10.3324/haematol.12682
pubmed: 18556406
Tincani E, Piccoli M, Turrini F, Crowther MA, Melotti G, Bondi M (2005) Video laparoscopic surgery: is out-of-hospital thromboprophylaxis necessary? J Thromb Haemost 3(2):216–220. https://doi.org/10.1111/j.1538-7836.2005.01111.x
doi: 10.1111/j.1538-7836.2005.01111.x
pubmed: 15670021
Das A, Bansal D, Ahluwalia J et al (2014) Risk factors for thromboembolism and pulmonary artery hypertension following splenectomy in children with hereditary spherocytosis. Pediatr Blood Cancer 61(1):29–33. https://doi.org/10.1002/pbc.24766
doi: 10.1002/pbc.24766
pubmed: 24038836
Troendle SB, Adix L, Crary SE, Buchanan GR (2007) Laboratory markers of thrombosis risk in children with hereditary spherocytosis. Pediatr Blood Cancer 49(6):781–785. https://doi.org/10.1002/pbc.21319
doi: 10.1002/pbc.21319
pubmed: 17854065